Investment List

74 investments found

Date	Investor	Investor*	Target	Round	Group	Amount (USD)	Country
2020-12-31	OrbiMed	OrbiMed	Immvira	Series C	4 Growth	—
2020-12-17	OrbiMed	OrbiMed	Cullinan Therapeutics	Series C	4 Growth	—
2020-12-08	OrbiMed	OrbiMed	RayzeBio	Series B	3 Early Growth	—
2020-12-08	OrbiMed	OrbiMed	Edgewise Therapeutics	Series C	4 Growth	—
2020-12-07	OrbiMed	OrbiMed	Syros Pharmaceuticals	Post-IPO Equity	6 Exit / Public	—
2020-12-07	OrbiMed	OrbiMed	Enliven Therapeutics	Series A	3 Early Growth	—
2020-11-20	OrbiMed	OrbiMed	VIVUS	Post-IPO Equity	6 Exit / Public	—
2020-11-19	OrbiMed	OrbiMed	Achilles Therapeutics	Series C	4 Growth	—
2020-11-18	OrbiMed	OrbiMed	Dami&Xiaomi	Series C	4 Growth	—
2020-11-10	OrbiMed	OrbiMed	Invivyd	Series B	3 Early Growth	—
2020-11-09	OrbiMed	OrbiMed	Decibel Therapeutics	Series D	4 Growth	—
2020-11-05	OrbiMed	OrbiMed	Cytek Biosciences	Series D	4 Growth	—
2020-10-30	OrbiMed	OrbiMed	Zylox	Series C	4 Growth	—
2020-10-29	OrbiMed	OrbiMed	Q32 Bio	Series B	3 Early Growth	—
2020-10-28	OrbiMed	OrbiMed	Gracell Biotechnologies	Series C	4 Growth	—
2020-10-27	OrbiMed	OrbiMed	Caris Life Sciences	Venture Round	7 Other	—
2020-10-22	OrbiMed	OrbiMed	Azura Ophthalmics	Series C	4 Growth	—
2020-10-20	OrbiMed	OrbiMed	BioNova Pharma	Series B	3 Early Growth	—
2020-10-19	OrbiMed	OrbiMed	VectivBio	Venture Round	7 Other	—
2020-10-12	OrbiMed	OrbiMed	Zhaoke Ophthalmology Pharmaceutical	Series B	3 Early Growth	—
2020-10-01	OrbiMed	OrbiMed	Olema Oncology	Series C	4 Growth	—
2020-09-29	OrbiMed	OrbiMed	Ruipeng Pet Healthcare	Venture Round	7 Other	—
2020-09-28	OrbiMed	OrbiMed	BioShin	Series A	3 Early Growth	—
2020-09-27	OrbiMed	OrbiMed	InventisBio	Series D	4 Growth	—
2020-09-25	OrbiMed	OrbiMed	Galecto	Series D	4 Growth	—
2020-09-23	OrbiMed	OrbiMed	Silverback Therapeutics	Series C	4 Growth	—
2020-09-23	OrbiMed	OrbiMed	Novellus	Series C	4 Growth	—
2020-09-21	OrbiMed	OrbiMed	Fore Biotherapeutics	Series C	4 Growth	—
2020-09-14	OrbiMed	OrbiMed	ESCAPE Bio	Series B	3 Early Growth	—
2020-09-14	OrbiMed	OrbiMed	Eledon Pharmaceuticals	Post-IPO Equity	6 Exit / Public	—
2020-09-04	OrbiMed	OrbiMed	I-Mab Biopharma	Post-IPO Equity	6 Exit / Public	—
2020-09-04	OrbiMed	OrbiMed	Angitia Biopharmaceuticals	Series A	3 Early Growth	—
2020-08-31	OrbiMed	OrbiMed	Erasca	Series B	3 Early Growth	—
2020-08-31	OrbiMed	OrbiMed	NeuroPace	Venture Round	7 Other	—
2020-08-26	OrbiMed	OrbiMed	Kinnate Biopharma	Series C	4 Growth	—
2020-08-25	OrbiMed	OrbiMed	ReViral	Series C	4 Growth	—
2020-08-24	OrbiMed	OrbiMed	Prelude Therapeutics	Series C	4 Growth	—
2020-08-18	OrbiMed	OrbiMed	ImmPACT Bio	Series A	3 Early Growth	—
2020-08-18	OrbiMed	OrbiMed	Chinook Therapeutics	Post-IPO Equity	6 Exit / Public	—
2020-08-17	OrbiMed	OrbiMed	Aerin Medical	Venture Round	7 Other	—
2020-08-12	OrbiMed	OrbiMed	MobileODT	Series C	4 Growth	—
2020-08-05	OrbiMed	OrbiMed	GentiBio	Seed Round	2 Seed	—
2020-08-03	OrbiMed	OrbiMed	PMV Pharmaceuticals	Series D	4 Growth	—
2020-07-29	OrbiMed	OrbiMed	Perfuse Therapeutics	Series A	3 Early Growth	—
2020-07-27	OrbiMed	OrbiMed	MBX Biosciences	Series A	3 Early Growth	—
2020-07-17	OrbiMed	OrbiMed	Verona Pharma	Post-IPO Equity	6 Exit / Public	—
2020-07-16	OrbiMed	OrbiMed	Invivyd	Series A	3 Early Growth	—
2020-07-10	OrbiMed	OrbiMed	New Horizon Health	Series E	4 Growth	—
2020-07-09	OrbiMed	OrbiMed	Harbour Biomed	Series C	4 Growth	—
2020-07-08	OrbiMed	OrbiMed	VelosBio	Series B	3 Early Growth	—
2020-07-06	OrbiMed	OrbiMed	Cogent Biosciences	Post-IPO Equity	6 Exit / Public	—
2020-07-01	OrbiMed	OrbiMed	Compass Therapeutics, Inc.	Venture Round	7 Other	—
2020-06-30	OrbiMed	OrbiMed	Prothelia	Venture Round	7 Other	—
2020-06-08	OrbiMed	OrbiMed	Norson Biotechnology	Series B	3 Early Growth	—
2020-06-08	OrbiMed	OrbiMed	MabPlex International	Series B	3 Early Growth	—
2020-06-04	OrbiMed	OrbiMed	Mereo Biopharma	Post-IPO Equity	6 Exit / Public	—
2020-05-27	OrbiMed	OrbiMed	Q32 Bio	Series A	3 Early Growth	—
2020-05-27	OrbiMed	OrbiMed	AbCellera	Series B	3 Early Growth	—
2020-05-21	OrbiMed	OrbiMed	Zentera Therapeutics	Series A	3 Early Growth	—
2020-04-24	OrbiMed	OrbiMed	TransMedics	Post-IPO Debt	6 Exit / Public	—
2020-04-07	OrbiMed	OrbiMed	TytoCare	Series D	4 Growth	—
2020-04-01	OrbiMed	OrbiMed	Aspen Neuroscience	Series A	3 Early Growth	—
2020-04-01	OrbiMed	OrbiMed	Pandion Therapeutics	Series B	3 Early Growth	—
2020-03-26	OrbiMed	OrbiMed	ReCode Therapeutics	Series A	3 Early Growth	—
2020-03-23	OrbiMed	OrbiMed	AbCellera	Series A	3 Early Growth	—
2020-03-17	OrbiMed	OrbiMed	Remegen	Private Equity Round	7 Other	—
2020-03-16	OrbiMed	OrbiMed	Rongchang Pharmaceutical	Series A	3 Early Growth	—
2020-03-11	OrbiMed	OrbiMed	Silverback Therapeutics	Series B	3 Early Growth	—
2020-03-04	OrbiMed	OrbiMed	Keros Therapeutics	Series C	4 Growth	—
2020-03-01	OrbiMed	OrbiMed	NewMed Medical	Series B	3 Early Growth	—
2020-01-27	OrbiMed	OrbiMed	Harmony Biosciences	Debt Financing	7 Other	—
2020-01-15	OrbiMed	OrbiMed	EmendoBio, Inc.	Series B	3 Early Growth	—
2020-01-08	OrbiMed	OrbiMed	VectivBio	Series A	3 Early Growth	—
2020-01-06	OrbiMed	OrbiMed	Sonendo	Venture Round	7 Other	—